Clinical trial
Producing a Novel Symptom Burden Scale for People Living With Idiopathic Multicentric Castleman Disease (ISBUS)
NCT05995834 is registered in ClinicalTrials.gov with RECORDATI GROUP as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Producing a Novel Symptom Burden Scale for People Living With Idiopathic Multicentric Castleman Disease (ISBUS)
- Lead sponsor
- RECORDATI GROUP
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- October 31, 2023
- Completion date
- December 31, 2024
- Enrollment
- 100 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
idiopathic multicentric castleman's disease